The Valley Desk

Clinical trial reportArthritis & rheumatology (Hoboken, N.J.)Published

Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Drexel University College of Medicine, with Drexel University linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Arthritis & rheumatology (Hoboken, N.J.)
Published
Subject terms
Humans; Arthritis, Psoriatic; Tumor Necrosis Factor-alpha; C-Reactive Protein; Serum Amyloid A Protein; Antirheumatic Agents; Interleukins; Interleukin-6; Interleukin-17; Treatment Outcome; Signal Transduction; Adult
PubMed ID
38253404
Added to directory
Source checked

Report a correction or request removal